Search


PDF Archive search engine
Last database update: 15 May at 07:37 - Around 76000 files indexed.


Show results per page

Results for «malate»:


Total: 13 results - 0.043 seconds

2013 Foray et al CBP 100%

Conversely, the metabolites that were positively correlated with PC1 (namely inositol, trehalose, fumarate, glutamate, phenylalanine, serine, malate, citrate and sucrose) increased with increasing developmental temperature (see Online Resource 1 for details).

https://www.pdf-archive.com/2015/07/07/2013-foray-et-al-cbp/

07/07/2015 www.pdf-archive.com

Halleluja 24122014 99%

E una festa meravigliosa, ma abbiamo il dovere di ricordarci anche delle Persone in guerra, malate, sofferenti, persone che non possono festeggiare perche le proibito celebrare questo grande miracolo di Dio.

https://www.pdf-archive.com/2014/12/24/halleluja-24122014/

24/12/2014 www.pdf-archive.com

治疗晚期肾癌药品舒尼替尼价格 99%

治疗晚期肾癌药品舒尼替尼价格 舒尼替尼胶囊说明: 舒尼替尼胶囊 Sunitinib Malate Capsules,由辉瑞公司生产,是一种口服的小分子多靶点受 体酪氨酸激酶抑制剂(receptor tyrosine kinase inhibitor ,rTKI)。具有抑制肿瘤血管生成和抗肿 瘤细胞生长的多重作用。该药发挥抗癌作用的靶点包括:PDGFR(PDGFRα和 PDGFR β),VEGFR(VEGFR1、VEGFR2、VEGFR3),FLT-3, CSF-1R,kit 和 ret。该药上市十几年来,基于大 量临床研究证据,已被多个国家和地区的医学指南推荐作为晚期肾细胞癌的一线治疗药物 (如美国、加拿大、欧洲、中国等)。该药在中国大陆的适应症为:1 甲磺酸伊马替尼治疗 失败或不能耐受的胃肠间质瘤(GIST);2 不能手术的晚期肾细胞癌(RCC);3 不可切除 的,转移性高分化进展期胰腺神经内分泌瘤(pNET)成年患者,本品作为一线治疗的经验 有限。 在国内晚期肾细胞癌的治疗方面,由于其起效迅速、耐受性良好,能够快速控制肿 瘤症状、与其他靶向药物相比具有较高的临床有效率、能够有效的控制肿瘤的进展,已得 到泌尿外科医生和肿瘤内科医生的普遍认可。由于舒尼替尼针对许多不同受体,它也带来 很多副作用,例如手足综合征、口腔炎和其它皮肤和皮下组织异常。随着临床用药经验的 丰富和个体化用药策略的实施,药物相关的不良反应已经得到有效的控制。 舒尼替尼胶囊价格: 由于舒尼替尼胶囊有良好的治愈效果,目前国内的价格大概在 131800 元/盒,这是在国内 市场调查的平均价格,跟实际价格还是有点差别的。但是在 apolopharmacy 上的价格大约 在 6000 元左右,由于每天的汇率都有所差异,具体的价格还是要根据你当天实际付款的价 格来了,不过价格相差也不会太大。 印度抗癌药品更多详情咨询 电话:0091-9205113743 电子邮箱:lifesmarthealthcare@gmail.com 官网:www.apolopharmacy.com

https://www.pdf-archive.com/2018/01/29/untitled-pdf-document-6/

29/01/2018 www.pdf-archive.com

CV2 95%

Malate, Manila reyalejandro.carbonmade.com reyanthonyalejandro@yahoo.com 09339264318 498-10-50 ABOUT ME I’m Passionate.

https://www.pdf-archive.com/2014/02/11/cv2/

11/02/2014 www.pdf-archive.com

2012 Colinet et al Funct Ecol 89%

A number of sugars (Suc, Fru, Tre), polyols (erythritol, sorbitol), FAAs (Val, Leu, Gly) and polyamines (Cad, Put) were more abundant in CA flies, while some metabolic intermediates, such as fumarate, malate, citrate and glycerate, were less abundant in CA flies (Fig.

https://www.pdf-archive.com/2015/07/07/2012-colinet-et-al-funct-ecol/

07/07/2015 www.pdf-archive.com

2012 Colinet et al PLOS One 82%

Other metabolites, such as fumarate, malate and citrate, were less abundant in D mummies (Figure 1) (about 1.5-2-fold).

https://www.pdf-archive.com/2015/07/07/2012-colinet-et-al-plos-one/

07/07/2015 www.pdf-archive.com

b. Programma di azione biennale per la promozione[...] 56%

Questo era, peraltro, l'impegno che l'Italia aveva assunto di fronte alla comunita' internazionale con la ratifica della Convenzione ONU sui diritti delle Persone con Disabilita' (Legge 18 del 2009) e che ha segnato il definitivo passaggio da una visione delle persone con disabilita' "come malate e minorate"

https://www.pdf-archive.com/2018/02/08/b-programma-di-azione-biennale-per-la-promozione/

08/02/2018 www.pdf-archive.com

2007 Lalouette Colinet et al. FEBS 42%

Oxidation of the keto acid in the citric acid cycle produces ATP and results in the formation of malate, which is first converted to pyruvate and then to Ala.

https://www.pdf-archive.com/2015/07/07/2007-lalouette-colinet-et-al-febs/

07/07/2015 www.pdf-archive.com

2016 Kostal et al Scientific Reports 40%

(iii) two upstream intermediates of TCA, citrate and aconitate, increased, whereas the others decreased (ketoglutarate, succinate, fumarate, and malate) suggesting a blockade of TCA at the locus of isocitrate dehydrogenase, which converts isocitrate to ketoglutarate.

https://www.pdf-archive.com/2016/08/31/2016-kostal-et-al-scientific-reports/

31/08/2016 www.pdf-archive.com

2014 Colinet Renault CBP-A 37%

Compounds abbreviations in brackets Free amino acids Alanine (Ala) Valine (Val) Serine (Ser) Leucine (Leu) Threonine (Thr) Proline (Pro) Methionine (Met) Ornithine (Orn) Glycine (Gly) Isoleucine (Ile) Glutamate (Glu) Lysine (Lys) Phenylalanine (Phe) Tyrosine (Tyr) Sugars Sucrose (Suc) Fructose (Fru) Glucose (Glc) Trehalose (Tre) Mannose (Man) Galactose (Gal) Ribose (Rib) Maltose (Mal) Glucose-6-phosphate (G6P) Polyols Sorbitol Glycerol Glycerol-3-phosphate Inositol Xylitol Intermediate metabolites Succinate Malate Citrate Fumarate Other metabolites Lactate Ethanolamine (ETA) Free phosphate (PO4) Gamma-aminobutyric acid (GABA) Glucono delta-lactone (GDL) Spermine between the nutritional groups.

https://www.pdf-archive.com/2015/07/07/2014-colinet-renault-cbp-a/

07/07/2015 www.pdf-archive.com

2018 Colinet & Renault Exp Gerontol 34%

Renault Leu Val 0.9 Gly 30 0.6 0.7 3.0 0.4 0.5 20 0.4 0.5 2.5 0.3 2.0 0.3 10 0.2 0.3 1.5 0.2 -1 0 2 4 8 -1 0 2 Ser Concentration (nmol/mg) Pro Ile 0.5 4 -1 8 0 2 Thr 4 -1 8 0 2 Ala 4 8 -1 0 2 Glu 3.0 4 8 4 8 4 8 4 8 Phe 10 1.00 12 0.4 2.5 8 0.75 9 2.0 0.3 6 0.50 1.5 6 0.25 1.0 -1 0 2 4 8 0.2 4 -1 0 2 Orn 4 8 -1 0 2 Rib 4 8 -1 0 2 Fru 4 8 -1 0 2 Glc Suc Concentration (nmol/mg) 4 0.040 0.30 20 6 3 0.035 0.25 15 4 2 0.030 10 0.20 2 0.025 1 5 0.020 0.15 0 0 -1 0 2 4 8 -1 0 Tre 2 4 8 -1 0 2 Mal 4 8 -1 0 2 GDL 4 8 -1 0 2 F6P G6P Concentration (nmol/mg) 1.1 30 3 2.0 4 1.5 2 3 1.0 15 0.5 1 2 0.5 10 1 0.3 0 2 4 8 -1 Succinate Concentration (nmol/mg) 0.7 20 -1 0 2 4 8 -1 0 2 Fumarate 4 8 -1 0 Malate 2 4 8 -1 0 2 Citrate Glycerol 1.8 3.5 1.0 0.175 4 1.5 3.0 0.150 3 0.8 1.2 2.5 0.6 0.125 2 2.0 0.9 0.100 1.5 0.4 -1 0 2 4 8 -1 G3R Concentration (nmol/mg) 5 0.9 25 0 2 4 8 1 -1 0 Sorbitol 2 4 8 -1 0 Inositol 2 4 8 0.75 14 2 4 8 4 8 4 8 0.07 0.30 0.100 0.25 0.075 0.20 0.050 0.06 0.05 0.50 10 0 Galacticol 0.35 18 -1 Erythritol 0.25 0.15 0.04 0.025 0.03 0.10 Concentration (nmol/mg) -1 0 2 4 8 -1 0 Mannitol 0.8 2 4 8 -1 Xylitol 0 2 4 8 -1 0 Citrulline 2 4 8 0.08 9 0.4 0.06 7 0.2 0.04 5 0.0 0.02 0 2 ETA 0.4 6 0.6 -1 PO4 5 0.3 4 -1 0 2 Time (h) 4 8 0.2 3 3 -1 0 2 Time (h) 4 8 -1 0 2 Time (h) 4 8 -1 0 2 Time (h) 4 8 -1 0 2 Time (h) Fig.

https://www.pdf-archive.com/2018/01/09/2018-colinet-renault-exp-gerontol/

09/01/2018 www.pdf-archive.com

ControCorrente02 31%

Negli appuntamenti di Controcorrente cercheremo di dare voce a nuove speranze, offrendo spazi di approfondimento e di confronto per chi come noi ancora in questo nostro Mediterraneo si batte per tenere aperta la strada di una stagione nuova contro le autarchie teutoniche e malate di chi ha creato conflitti, contraddizioni ,tragedie nel nostro tempo, dalle migrazioni all'instabilità politica, dalla diffusione del terrorismo anche mediatico ,alle nuove forme di colonialismo economico e guerra, dalla crescita di nazionalismi e populismi alla crisi della democrazia.

https://www.pdf-archive.com/2017/01/23/controcorrente02/

23/01/2017 www.pdf-archive.com